Oblend Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Oblend General Information
Description
Developer of therapeutic plant-based ingredients designed to facilitate the mixing and dispensing of botanical oils. The company's ingredients are used for mixing and dispensing botanical oils to create customized oil blends for on-demand, precise, and single-use consumption, enabling medical professionals to develop their own shampoos, vitamins and perfumes.
Contact Information
Website
www.oblend.comCorporate Office
- 303 Dunwoody Drive
- Raleigh, NC 27615
- United States
Corporate Office
- 303 Dunwoody Drive
- Raleigh, NC 27615
- United States
Oblend Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 14-Jan-2026 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 09-Aug-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 28-Dec-2018 | $3.76M | $5.16M | Completed | Generating Revenue | |
| 1. Seed Round | 25-Jul-2017 | $1.4M | $1.4M | Completed | Generating Revenue |
Oblend Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed |
Oblend Patents
Oblend Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230390310-A1 | Personalized, precise, consistent botanical formulations on demand | Pending | 03-Jun-2022 | ||
| CA-3171615-A1 | Precision control and characterization of dispensed substances | Pending | 13-Mar-2020 | ||
| EP-4117492-A1 | Precision control and characterization of dispensed substances | Inactive | 13-Mar-2020 | ||
| US-12524026-B2 | Precision control and characterization of dispensed substances | Active | 13-Mar-2020 | ||
| US-20230046651-A1 | Precision control and characterization of dispensed substances | Active | 13-Mar-2020 | A47J36/321 |
Oblend Signals
Oblend Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| WTIA Startup Program | Accelerator/Incubator |
Oblend FAQs
-
When was Oblend founded?
Oblend was founded in 2016.
-
Where is Oblend headquartered?
Oblend is headquartered in Raleigh, NC.
-
What is the size of Oblend?
Oblend has 4 total employees.
-
What industry is Oblend in?
Oblend’s primary industry is Other Devices and Supplies.
-
Is Oblend a private or public company?
Oblend is a Private company.
-
What is Oblend’s current revenue?
The current revenue for Oblend is .
-
How much funding has Oblend raised over time?
Oblend has raised $5.16M.
-
Who are Oblend’s investors?
WTIA Startup Program has invested in Oblend.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process